3-D Matrix Ltd (DMTRF) fair value: what the stock is really worth
As of Sep 18, 2026: fair value of 3-D Matrix Ltd $0.91, price $2.50, upside -63.6%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch 3-D Matrix Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range $0.6900 – $4.75 · fair‑value band $0.4590 – $1.56 · the $2.50 price screens above the $0.9095 fair value. Dashed = 300-day average. As of Sep 23, 2026.
Follow 3-D Matrix in your weekly email
Every Wednesday you see whether 3-D Matrix is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan
Stock analysis
3-D Matrix Ltd (DMTRF) currently trades at $2.50, while our model-based Fair Value estimate is $0.9095, implying the stock looks roughly 174.9% overvalued today.
Show more
Valuation
Bull case: the Earnings-Based group reads highest at a median of $7.64 per share, and 9 of the 24 models we run sit above the $2.50 price.
Bear case: the Asset-Based group reads lowest at $0.2391, and 15 of the 24 models stay below the price. Evidence for this calculation is medium.
Scenario range: $0.4590 (bear) to $1.56 (bull), the price of $2.50 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
3-D Matrix Ltd reported revenue of ¥10.9B in FY2026 versus ¥1.5B in FY2022, a compound +63.9%/yr. Reported net income was ¥4.1B in FY2026.
Key figures
Market cap $336M · P/E ratio 11.4 · P/S ratio 4.34 · EPS (TTM) $0.2200 · Net margin 38.2% · Return on equity 92.2% · Return on assets (EBIT) −28.6% · Operating margin 17.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 58 out of 100 (medium confidence).
What moves the price
The share trades about 37% below its 52-week high and 67% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at −64%, DMTRF screens richer than that median.
Fair Value models
Bear $0.4590Fair Value $0.9095Bull $1.56
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 5 months old). Earnings retained since then ($0.0892 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.72/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+56.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+67.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+60.4%
Start year 2021 (pandemic). Over 10 years: +54.3% a year
Revenue growth 15 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+32.6%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−258.6% (2021) → 12.3% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+58.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in JPY, Japan: IMF forecast 2.1% a year to 2030, 1.3% from 2016 to 2025) that is about +54.9% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 365 stocks
Beats the industry median on 8/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score60 · Above median
Fair Value upside−64% · Bottom 25%
Profitability
Return on equity (TTM)92% · Top 25%
Return on assets10% · Top 25%
Net margin (TTM)38% · Top 25%
Operating margin (TTM)18% · Top 25%
Growth and dividend
Revenue growth89% · Top 25%
Balance sheet
Debt / equity0.39× · Highest 25%
Valuation Multiplesvs Medical Devices median · lower = cheaper
P/E (TTM)11.4× · Cheapest 25%
P/B7.86× · Priciest 25%
P/S (TTM)4.90× · Priciest 25%
P/FCF0.9× · Cheapest 25%
EV/EBITDA39.8× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 10
FUTURE (revenue growth)100· sector 31
PAST (return on equity)100· sector 7
HEALTH (low debt)81· sector 97
DIVIDEND (yield)0· sector 40
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is 3-D Matrix Ltd (DMTRF) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of $0.9095 versus the last price from Sep 18, 2026 of $2.50, about −64% upside (overvalued).
What is the fair value of DMTRF?
Our model-based fair value for 3-D Matrix Ltd is $0.9095 (as of Sep 23, 2026), built from audited fundamentals. Last price (from Sep 18, 2026): $2.50.
What is the quality score of DMTRF?
3-D Matrix Ltd has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for 3-D Matrix Ltd (DMTRF)?
Our model-based price target is the fair value of $0.9095 (as of Sep 23, 2026) from 24 valuation models. Cautious scenario $0.4590, optimistic scenario $1.56. It is a calculation from audited fundamentals, not an analyst target.
What is the 3-D Matrix Ltd stock forecast for 2026?
Our models put fair value at $0.9095, about −64% upside versus the last price from Sep 18, 2026 of $2.50 (overvalued). Cautious scenario $0.4590, optimistic scenario $1.56. The calculation is refreshed regularly with new filings.
What is the revenue of 3-D Matrix Ltd (DMTRF)?
3-D Matrix Ltd reported trailing-twelve-month revenue of about ¥10.9B (latest available figure, as of Sep 23, 2026).
What growth is priced into 3-D Matrix Ltd (DMTRF)?
For today's price to be fair in a discounted-cash-flow model, 3-D Matrix Ltd would have to grow free cash flow by +58.2 % per year for five years (discount rate 12.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +60.4 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of DMTRF use?
Our models discount 3-D Matrix Ltd at 12.5 %: a base by market capitalisation (micro), damped by beta 0.92, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For 3-D Matrix Ltd that is +58.2 % per year a year over ten years, using the same discount rate (12.5 %) and the same formula as our fair value.
How much growth has 3-D Matrix Ltd (DMTRF) delivered so far?
Over the past 5 years revenue at 3-D Matrix Ltd grew +60.4 % a year. The price currently implies +58.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of 3-D Matrix Ltd (DMTRF) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into 3-D Matrix Ltd (+58.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of 3-D Matrix Ltd (DMTRF)?
The free-cash-flow yield on the price is 0.69 %: that much free cash flow 3-D Matrix Ltd produces per unit of market value. When it exceeds the discount rate of our models (12.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of 3-D Matrix Ltd (DMTRF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For 3-D Matrix Ltd it is $0.9095 per share (as of Sep 23, 2026), against a price of $2.50. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is 3-D Matrix Ltd stock overvalued or undervalued in 2026?
As of Sep 23, 2026, DMTRF trades above its calculated fair value: price $2.50, fair value $0.9095, a gap of about −64% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DMTRF?
No. The price is what the market pays today ($2.50); the fair value is what the company's own numbers justify ($0.9095). For 3-D Matrix Ltd the two are $1.59 per share apart. That gap is exactly why we show both numbers side by side.
How much is 3-D Matrix Ltd worth?
The market values 3-D Matrix Ltd at about $336M (market capitalisation, as of Sep 23, 2026). Per share that is $2.50; our models calculate a fair value of $0.9095 per share.
What do the bullish and bearish scenarios say about DMTRF?
Our models span a range for 3-D Matrix Ltd: cautious scenario $0.4590, base $0.9095, optimistic $1.56 per share (as of Sep 23, 2026, price $2.50). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of DMTRF?
3-D Matrix Ltd trades at a price-to-earnings ratio of 11.4 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $0.9095 is built from several models across several years. Other multiples: P/B 7.9, P/S 4.9, EV/EBITDA 39.8.
How solid is the balance sheet of 3-D Matrix Ltd (DMTRF)?
Balance-sheet figures for 3-D Matrix Ltd (as of Sep 23, 2026): return on equity 92.2%, debt of 0.39 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is DMTRF from its 52-week high?
3-D Matrix Ltd trades at $2.50, about 37% below its 52-week high of $3.96 and 67% above the low of $1.50 (as of Sep 18, 2026). Distance from the high says nothing about value: that is what the fair value of $0.9095 is for.
Which stocks are comparable to 3-D Matrix Ltd?
From the same area (Healthcare) we also value Abbott Laboratories,, Stryker Corporation, Medtronic plc, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is 3-D Matrix Ltd stock attractive at the current price?
The data as of Sep 23, 2026: price $2.50, calculated fair value $0.9095 (−64%), Quality Score 60/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DMTRF calculated?
We run 3-D Matrix Ltd through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.9095, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. 3-D Matrix Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of 3-D Matrix Ltd (DMTRF)?
The latest price we hold is from Sep 18, 2026 and stands at $2.50. Our model-based fair value is $0.9095, about −64% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with 3-D Matrix Ltd right now?
The price sits above even our optimistic bull case ($1.56). The favourable scenario is already priced in. The model range is unusually wide ($0.4590 to $1.56). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of 3-D Matrix Ltd
How large is the market capitalisation of 3-D Matrix Ltd (DMTRF)?
The market capitalisation of 3-D Matrix Ltd is $336M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of 3-D Matrix Ltd (DMTRF)?
The price-to-sales ratio of 3-D Matrix Ltd is 4.34 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of 3-D Matrix Ltd (DMTRF)?
Earnings per share at 3-D Matrix Ltd are $0.2200 (price ÷ EPS = P/E 11.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of 3-D Matrix Ltd (DMTRF)?
The net margin of 3-D Matrix Ltd is 38.2% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of 3-D Matrix Ltd (DMTRF)?
The return on equity (ROE) of 3-D Matrix Ltd is 92.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of 3-D Matrix Ltd (DMTRF)?
On an EBIT basis the return on assets of 3-D Matrix Ltd is −28.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of 3-D Matrix Ltd (DMTRF)?
The operating margin of 3-D Matrix Ltd is 17.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at 3-D Matrix Ltd (DMTRF)?
Revenue at 3-D Matrix Ltd is growing +88.8% versus a year earlier (3y avg +67.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net cash does 3-D Matrix Ltd (DMTRF) hold?
3-D Matrix Ltd holds more cash than debt, ¥2.2B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch 3-D Matrix Ltd in the live analysis
One click puts 3-D Matrix Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Some data
Sep 23, 2026